{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:54:56Z","timestamp":1794048896467,"version":"4.8.0"},"reference-count":81,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lymphangioleiomyomatosis (LAM) is a rare, progressive lung disease that predominantly affects women, particularly during their reproductive years. It is characterized by the proliferation of abnormal smooth muscle-like cells that infiltrate the lungs, leading to cystic destruction of lung tissue and a decline in respiratory function. The pathogenic defect in LAM occurs due to mutations in the tuberous sclerosis complex genes, resulting in failure to suppress the mTOR pathway activation, which drives abnormal cell proliferation and lymphangiogenesis. Although mTOR inhibitors, such as sirolimus, have improved clinical management by slowing disease progression, they are not curative and do not reverse existing lung damage. Recent research has expanded our understanding of LAM pathogenesis by revealing substantial genetic and cellular heterogeneity within LAM lesions. Beyond mTOR dysregulation, pathways involving estrogen signaling, metabolic adaptation, and immune evasion contribute to disease development. These insights open new avenues for treatment. A better understanding of these pathways will pave the way for more durable and individualized treatments for LAM.<\/jats:p>","DOI":"10.1093\/ajrcmb\/aanag042","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:51:56Z","timestamp":1772628716000},"page":"1352-1363","source":"Crossref","is-referenced-by-count":1,"title":["Current insight into the molecular mechanisms of lymphangioleiomyomatosis"],"prefix":"10.1093","volume":"74","author":[{"given":"Amina","family":"Jouida","sequence":"first","affiliation":[{"name":"University College Dublin School of Medicine, , Dublin,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P","family":"Keane","sequence":"additional","affiliation":[{"name":"University College Dublin School of Medicine, , Dublin,","place":["Ireland"]},{"name":"St. Vincent\u2019s University Hospital Department of Respiratory Medicine, , Dublin,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cormac","family":"McCarthy","sequence":"additional","affiliation":[{"name":"University College Dublin School of Medicine, , Dublin,","place":["Ireland"]},{"name":"St. Vincent\u2019s University Hospital Department of Respiratory Medicine, , Dublin,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"2026093004090626200_aanag042-B1","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/S2213-2600(21)00228-9","article-title":"Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management","volume":"9","author":"McCarthy","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2026093004090626200_aanag042-B2","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1164\/rccm.202310-1736LE","article-title":"Updated prevalence of lymphangioleiomyomatosis in Europe","volume":"209","author":"Lynn","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026093004090626200_aanag042-B3","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1164\/rccm.202312-2254ED","article-title":"Lymphangioleiomyomatosis: no longer ultra-rare","volume":"209","author":"Gupta","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026093004090626200_aanag042-B4","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1172\/JCI58709","article-title":"Lymphangioleiomyomatosis\u2013a wolf in sheep\u2019s clothing","volume":"122","author":"Henske","year":"2012","journal-title":"J Clin Invest"},{"key":"2026093004090626200_aanag042-B5","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1164\/rccm.201912-2445OC","article-title":"Single-cell transcriptomic analysis identifies a unique pulmonary lymphangioleiomyomatosis cell","volume":"202","author":"Guo","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2026093004090626200_aanag042-B6","doi-asserted-by":"publisher","first-page":"30958","DOI":"10.1074\/jbc.M202678200","article-title":"Tuberin \u00adregulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation: a role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM)","volume":"277","author":"Goncharova","year":"2002","journal-title":"J Biol Chem"},{"key":"2026093004090626200_aanag042-B7","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"2026093004090626200_aanag042-B8","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1164\/rccm.201405-0918OC","article-title":"Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis","volume":"190","author":"Yao","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026093004090626200_aanag042-B9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S2213-2600(13)70090-0","article-title":"Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial","volume":"1","author":"Young","year":"2013","journal-title":"Lancet Respir Med"},{"key":"2026093004090626200_aanag042-B10","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1042\/BST0390466","article-title":"The tuberous sclerosis complex: balancing proliferation and survival","volume":"39","author":"Tomasoni","year":"2011","journal-title":"Biochem Soc Trans"},{"key":"2026093004090626200_aanag042-B11","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/j.rmed.2010.03.017","article-title":"Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies","volume":"104(suppl 1)","author":"Glasgow","year":"2010","journal-title":"Respir Med"},{"key":"2026093004090626200_aanag042-B12","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.cell.2006.06.055","article-title":"TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth","volume":"126","author":"Inoki","year":"2006","journal-title":"Cell"},{"key":"2026093004090626200_aanag042-B13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00439-006-0308-9","article-title":"Identification of 54 large deletions\/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations","volume":"121","author":"Kozlowski","year":"2007","journal-title":"Hum Genet"},{"key":"2026093004090626200_aanag042-B14","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/modpathol.2017.52","article-title":"Genomic rearrangements in sporadic lymphangioleiomyomatosis: an evolving genetic story","volume":"30","author":"Murphy","year":"2017","journal-title":"Mod Pathol"},{"key":"2026093004090626200_aanag042-B15","doi-asserted-by":"publisher","first-page":"1900938","DOI":"10.1183\/13993003.00938-2019","article-title":"Generalised mosaicism for TSC2 mutation in isolated lymphangioleiomyomatosis","volume":"54","author":"Og\u00f3rek","year":"2019","journal-title":"Eur Respir J"},{"key":"2026093004090626200_aanag042-B16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/qjmed\/hcad235","article-title":"Sporadic lymphangioleiomyomatosis in a man with somatic mosaicism of TSC2 mutations, a case report","volume":"117","author":"Wang","year":"2024","journal-title":"QJM"},{"key":"2026093004090626200_aanag042-B17","doi-asserted-by":"publisher","first-page":"1900329","DOI":"10.1183\/13993003.00329-2019","article-title":"A genome-wide association study implicates NR2F2 in lymphangioleiomyomatosis pathogenesis","volume":"53","author":"Kim","year":"2019","journal-title":"Eur Respir J"},{"key":"2026093004090626200_aanag042-B18","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s12890-022-02154-0","article-title":"Gene mutations in sporadic lymphangioleiomyomatosis and genotype\u2013phenotype correlation analysis","volume":"22","author":"Huang","year":"2022","journal-title":"BMC Pulm Med"},{"key":"2026093004090626200_aanag042-B19","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1158\/1541-7786.MCR-18-1292","article-title":"The codon 72 TP53 polymorphism contributes to TSC tumorigenesis through the notch\u2013nodal axis","volume":"17","author":"Cho","year":"2019","journal-title":"Mol Cancer Res"},{"key":"2026093004090626200_aanag042-B20","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1158\/1541-7786.MCR-21-0220","article-title":"Heterogeneity and cancer-related features in lymphangioleiomyomatosis cells and tissue","volume":"19","author":"Esp\u00edn","year":"2021","journal-title":"Mol Cancer Res"},{"key":"2026093004090626200_aanag042-B21","doi-asserted-by":"publisher","first-page":"eadf8549","DOI":"10.1126\/sciadv.adf8549","article-title":"Single-cell multiomic analysis identifies a HOX-PBX gene network regulating the survival of lymphangioleiomyomatosis cells","volume":"9","author":"Olatoke","year":"2023","journal-title":"Sci Adv"},{"key":"2026093004090626200_aanag042-B22","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.2353\/ajpath.2010.090233","article-title":"Tuberin regulates E-cadherin localization: implications in epithelial-mesenchymal transition","volume":"177","author":"Barnes","year":"2010","journal-title":"Am J Pathol"},{"key":"2026093004090626200_aanag042-B23","doi-asserted-by":"publisher","first-page":"e2302611","DOI":"10.1002\/advs.202302611","article-title":"Tissue-engineered disease modeling of lymphangioleiomyomatosis exposes a therapeutic vulnerability to HDAC inhibition","volume":"10","author":"Pietrobon","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"2026093004090626200_aanag042-B24","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00492-2025","article-title":"Extracellular matrix deposition drives disease progression and reduces rapamycin response in LAM","author":"Clements","journal-title":"Eur Respir J"},{"key":"2026093004090626200_aanag042-B25","doi-asserted-by":"publisher","first-page":"e187899","DOI":"10.1172\/jci.insight.187899","article-title":"Targeting fibroblast\u2013endothelial cell interactions in LAM pathogenesis using 3D spheroid models and spatial transcriptomics","volume":"10","author":"Koc-Gunel","year":"2025","journal-title":"JCI Insight"},{"key":"2026093004090626200_aanag042-B26","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0100-2023","article-title":"Lost in translation: a neglected mTOR target for lymphangioleiomyomatosis","volume":"32","author":"Evans","year":"2023","journal-title":"Eur Respir Rev"},{"key":"2026093004090626200_aanag042-B27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1165\/rcmb.2009-0050OC","article-title":"Rapamycin-insensitive up-regulation of MMP2 and other genes in tuberous sclerosis complex 2\u2013deficient lymphangioleiomyomatosis-like cells","volume":"42","author":"Lee","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026093004090626200_aanag042-B28","doi-asserted-by":"publisher","first-page":"8110","DOI":"10.1002\/jcp.30465","article-title":"\u03b1B-crystallin\/HSPB2 is critical for hyperactive mTOR-induced cardiomyopathy","volume":"236","author":"Wang","year":"2021","journal-title":"J Cell Physiol"},{"key":"2026093004090626200_aanag042-B29","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1038\/s41467-021-24499-6","article-title":"TSC2 regulates lysosome biogenesis via a non-canonical RAGC and TFEB-dependent mechanism","volume":"12","author":"Alesi","year":"2021","journal-title":"Nat Commun"},{"key":"2026093004090626200_aanag042-B30","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41467-023-44229-4","article-title":"TFEB drives mTORC1 hyperactivation and kidney disease in tuberous sclerosis complex","volume":"15","author":"Alesi","year":"2024","journal-title":"Nat Commun"},{"key":"2026093004090626200_aanag042-B31","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1038\/s41467-021-24056-1","article-title":"CIB2 regulates mTORC1 signaling and is essential for autophagy and visual function","volume":"12","author":"Sethna","year":"2021","journal-title":"Nat Commun"},{"key":"2026093004090626200_aanag042-B32","doi-asserted-by":"publisher","first-page":"7367","DOI":"10.1038\/s41388-019-0957-5","article-title":"Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor \u03b2 (RAR\u03b2)","volume":"38","author":"Liu","year":"2019","journal-title":"Oncogene"},{"key":"2026093004090626200_aanag042-B33","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1136\/thoraxjnl-2020-214987","article-title":"Pregnancy in lymphangioleiomyomatosis: clinical and lung function outcomes in two national cohorts","volume":"75","author":"Taveira-DaSilva","year":"2020","journal-title":"Thorax"},{"key":"2026093004090626200_aanag042-B34","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1378\/chest.91.5.782","article-title":"Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous estrogens","volume":"91","author":"Shen","year":"1987","journal-title":"Chest"},{"key":"2026093004090626200_aanag042-B35","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1136\/thorax.57.12.1085","article-title":"Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous oestrogen used for infertility treatment","volume":"57","author":"Yano","year":"2002","journal-title":"Thorax"},{"key":"2026093004090626200_aanag042-B36","doi-asserted-by":"publisher","first-page":"L694","DOI":"10.1152\/ajplung.00204.2003","article-title":"Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways","volume":"286","author":"Yu","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026093004090626200_aanag042-B37","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1073\/pnas.0810790106","article-title":"Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells","volume":"106","author":"Yu","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026093004090626200_aanag042-B38","doi-asserted-by":"publisher","first-page":"14960","DOI":"10.1073\/pnas.1309110110","article-title":"Integration of mTOR and estrogen\u2013ERK2 signaling in lymphangioleiomyomatosis pathogenesis","volume":"110","author":"Gu","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026093004090626200_aanag042-B39","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.febslet.2009.11.041","article-title":"mTOR\/S6K1 and MAPK\/RSK signaling pathways coordinately regulate estrogen receptor alpha serine 167 phosphorylation","volume":"584","author":"Yamnik","year":"2010","journal-title":"FEBS Lett"},{"key":"2026093004090626200_aanag042-B40","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1038\/onc.2015.414","article-title":"mTORC1 directly phosphorylates and activates ER\u03b1 upon estrogen stimulation","volume":"35","author":"Alayev","year":"2016","journal-title":"Oncogene"},{"key":"2026093004090626200_aanag042-B41","doi-asserted-by":"publisher","first-page":"e1231","DOI":"10.1038\/cddis.2014.204","article-title":"Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells","volume":"5","author":"Sun","year":"2014","journal-title":"Cell Death Dis"},{"key":"2026093004090626200_aanag042-B42","doi-asserted-by":"publisher","first-page":"e13929","DOI":"10.15252\/emmm.202113929","article-title":"Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis","volume":"13","author":"Herranz","year":"2021","journal-title":"EMBO Mol Med"},{"key":"2026093004090626200_aanag042-B43","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1164\/rccm.202007-2854OC","article-title":"Mast-cell tryptase release contributes to disease progression in lymphangioleiomyomatosis","volume":"204","author":"Babaei-Jadidi","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2026093004090626200_aanag042-B44","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1172\/JCI37964","article-title":"Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3\/p63\/jagged\/notch Cascade","volume":"120","author":"Ma","year":"2010","journal-title":"J Clin Invest"},{"key":"2026093004090626200_aanag042-B45","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1124\/mol.109.057042","article-title":"Signal transducer and activator of transcription 3 is required for abnormal proliferation and survival of TSC2-deficient cells: relevance to pulmonary lymphangioleiomyomatosis","volume":"76","author":"Goncharova","year":"2009","journal-title":"Mol Pharmacol"},{"key":"2026093004090626200_aanag042-B46","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1038\/s41467-017-01845-1","article-title":"Notch transactivates RHEB to maintain the multipotency of TSC-null cells","volume":"8","author":"Cho","year":"2017","journal-title":"Nat Commun"},{"key":"2026093004090626200_aanag042-B47","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1165\/rcmb.2024-0111OC","article-title":"Enhanced g\u03b1q signaling in TSC2-deficient cells is required for their neoplastic behavior","volume":"72","author":"Tr\u00e9fier","year":"2025","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026093004090626200_aanag042-B48","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.3892\/or.2018.6916","article-title":"miR\u2011124 targets retinoid X receptor \u03b1 to reduce growth of TSC2\u2011deficient lymphangioleiomyomatosis","volume":"41","author":"Liu","year":"2019","journal-title":"Oncol Rep"},{"key":"2026093004090626200_aanag042-B49","doi-asserted-by":"publisher","first-page":"14161","DOI":"10.1038\/s41598-018-32256-x","article-title":"Vps34-mediated macropinocytosis in tuberous sclerosis complex 2-deficient cells supports tumorigenesis","volume":"8","author":"Filippakis","year":"2018","journal-title":"Sci Rep"},{"key":"2026093004090626200_aanag042-B50","doi-asserted-by":"publisher","first-page":"e2101268118","DOI":"10.1073\/pnas.2101268118","article-title":"Interleukin-6 mediates PSAT1 expression and serine metabolism in TSC2-deficient cells","volume":"118","author":"Wang","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026093004090626200_aanag042-B51","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.molcel.2010.05.007","article-title":"Glucose addiction of TSC-null cells is caused by failed mTORC1-dependent \u00adbalancing of metabolic demand with supply","volume":"38","author":"Choo","year":"2010","journal-title":"Mol Cell"},{"key":"2026093004090626200_aanag042-B52","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"D\u00fcvel","year":"2010","journal-title":"Mol Cell"},{"key":"2026093004090626200_aanag042-B53","doi-asserted-by":"publisher","first-page":"e1333","DOI":"10.1002\/ctm2.1333","article-title":"Glutaredoxin-1 promotes lymphangioleiomyomatosis progression through inhibiting Bim-mediated apoptosis via COX2\/PGE2\/ERK pathway","volume":"13","author":"Feng","year":"2023","journal-title":"Clin Transl Med"},{"key":"2026093004090626200_aanag042-B54","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1158\/0008-5472.CAN-13-1256","article-title":"SRC kinase is a novel therapeutic target in lymphangioleiomyomatosis","volume":"74","author":"Tyryshkin","year":"2014","journal-title":"Cancer Res"},{"key":"2026093004090626200_aanag042-B55","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.ajpath.2013.05.024","article-title":"Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene","volume":"183","author":"Steagall","year":"2013","journal-title":"Am J Pathol"},{"key":"2026093004090626200_aanag042-B56","doi-asserted-by":"publisher","first-page":"L703","DOI":"10.1152\/ajplung.00414.2011","article-title":"TSC2 modulates cell adhesion and migration via integrin-\u03b11\u03b21","volume":"303","author":"Moir","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026093004090626200_aanag042-B57","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/modpathol.2008.189","article-title":"Cathepsin-K expression in pulmonary lymphangioleiomyomatosis","volume":"22","author":"Chilosi","year":"2009","journal-title":"Mod Pathol"},{"key":"2026093004090626200_aanag042-B58","doi-asserted-by":"publisher","first-page":"267","DOI":"10.5858\/2000-124-0267-RFAOMM","article-title":"Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis","volume":"124","author":"Matsui","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"2026093004090626200_aanag042-B59","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.rmed.2008.07.017","article-title":"Matrix metalloproteinases in blood from patients with LAM","volume":"103","author":"Odajima","year":"2009","journal-title":"Respir Med"},{"key":"2026093004090626200_aanag042-B60","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.3390\/biomedi\u00adcines9121760","article-title":"Differential modu\u00adlation of matrix metalloproteinases-2 and -7 in LAM\/TSC cells","volume":"9","author":"Ancona","year":"2021","journal-title":"Biomedicines"},{"key":"2026093004090626200_aanag042-B61","doi-asserted-by":"publisher","first-page":"605909","DOI":"10.3389\/fmed.2021.605909","article-title":"Exploring the role of matrix metalloproteinases as biomarkers in sporadic lymphangioleiomyomatosis and tuberous sclerosis complex: a pilot study","volume":"8","author":"Terraneo","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2026093004090626200_aanag042-B62","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02455-2024","article-title":"Small extracellular vesicles and induction of epithelial to mesenchymal transition in lymphangioleiomyomatosis","author":"Jouida","year":"2025","journal-title":"Eur Respir J"},{"key":"2026093004090626200_aanag042-B63","doi-asserted-by":"publisher","first-page":"6543","DOI":"10.1038\/onc.2010.393","article-title":"Rheb activates AMPK and reduces p27Kip1 levels in Tsc2-null cells via mTORC1-independent mechanisms: implications for cell proliferation and tumorigenesis","volume":"29","author":"Lacher","year":"2010","journal-title":"Oncogene"},{"key":"2026093004090626200_aanag042-B64","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev-med-050715-104245","article-title":"Lymphangioleiomyomatosis: a monogenic model of malignancy","volume":"68","author":"Krymskaya","year":"2017","journal-title":"Annu Rev Med"},{"key":"2026093004090626200_aanag042-B65","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1165\/rcmb.2017-0403TR","article-title":"The lymphangioleiomyomatosis lung cell and its human cell models","volume":"58","author":"Steagall","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026093004090626200_aanag042-B66","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1164\/rccm.201003-0489OC","article-title":"Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis","volume":"182","author":"Cai","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026093004090626200_aanag042-B67","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1164\/rccm.200208-969OC","article-title":"Recurrent lymphangiomyomatosis after transplantation","volume":"167","author":"Karbowniczek","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"2026093004090626200_aanag042-B68","doi-asserted-by":"publisher","first-page":"17462","DOI":"10.1073\/pnas.0407971101","article-title":"Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis","volume":"101","author":"Crooks","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026093004090626200_aanag042-B69","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1210\/me.2013-1059","article-title":"Uterine-specific loss of Tsc2 leads to myometrial tumors in both the uterus and lungs","volume":"27","author":"Prizant","year":"2013","journal-title":"Mol Endocrinol"},{"key":"2026093004090626200_aanag042-B70","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13023-025-03802-4","article-title":"Associations of VEGF-D levels with clinical manifestations in lymphangioleiomyomatosis: a cross-sectional analysis of 631 cases","volume":"20","author":"Yang","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"2026093004090626200_aanag042-B71","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1378\/chest.08-1160","article-title":"Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement","volume":"135","author":"Glasgow","year":"2009","journal-title":"Chest"},{"key":"2026093004090626200_aanag042-B72","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1196\/annals.1413.018","article-title":"Lymphatic involvement in lymphangioleiomyomatosis","volume":"1131","author":"Glasgow","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"2026093004090626200_aanag042-B73","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1183\/09059180.00009311","article-title":"Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis","volume":"21","author":"Glasgow","year":"2012","journal-title":"Eur Respir Rev"},{"key":"2026093004090626200_aanag042-B74","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1369\/0022155413489311","article-title":"Lymphatic endothelial differentiation in pulmonary lymphangioleiomyomatosis cells","volume":"61","author":"Davis","year":"2013","journal-title":"J Histochem Cytochem"},{"key":"2026093004090626200_aanag042-B75","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.chest.2017.05.012","article-title":"Long-term effect of sirolimus on serum vascular endothelial growth factor D levels in patients with lymphangioleiomyomatosis","volume":"153","author":"Taveira-DaSilva","year":"2018","journal-title":"Chest"},{"key":"2026093004090626200_aanag042-B76","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41467-023-36881-7","article-title":"mTORC1 upregulates B7-H3\/CD276 to inhibit antitumor T cells and drive tumor immune evasion","volume":"14","author":"Liu","year":"2023","journal-title":"Nat Commun"},{"key":"2026093004090626200_aanag042-B77","doi-asserted-by":"publisher","first-page":"e87270","DOI":"10.1172\/jci.insight.87270","article-title":"NK cell activating receptor ligand expression in lymphangioleiomyomatosis is associated with lung function decline","volume":"1","author":"Osterburg","year":"2016","journal-title":"JCI Insight"},{"key":"2026093004090626200_aanag042-B78","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.4049\/jimmunol.182.3.1270","article-title":"Chemokine-enhanced chemotaxis of lymphangioleiomyomatosis cells with mutations in the tumor suppressor TSC2 gene","volume":"182","author":"Pacheco-Rodriguez","year":"2009","journal-title":"J Immunol"},{"key":"2026093004090626200_aanag042-B79","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1084\/jem.20042469","article-title":"MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development","volume":"202","author":"Li","year":"2005","journal-title":"J Exp Med"},{"key":"2026093004090626200_aanag042-B80","doi-asserted-by":"publisher","first-page":"2500084","DOI":"10.1183\/13993003.00084-2025","article-title":"Modulation of infiltrating CD206-positive macrophages restricts progression of \u00adpulmonary lymphangioleiomyomatosis (LAM)","volume":"66","author":"Liu","year":"2025","journal-title":"Eur Respir J"},{"key":"2026093004090626200_aanag042-B81","doi-asserted-by":"publisher","first-page":"578-588","DOI":"10.1016\/j.ijbiomac.2016.12.062","article-title":"Repression of TSC1\/TSC2 mediated by MeCP2 regulates human embryo lung fibroblast cell differentiation and proliferation","volume":"96","author":"Wang","year":"2017","journal-title":"Int J Biol Macromol"}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/advance-article-pdf\/doi\/10.1093\/ajrcmb\/aanag042\/67348644\/aanag042.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/74\/10\/1352\/67348644\/aanag042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/74\/10\/1352\/67348644\/aanag042.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:09:19Z","timestamp":1790755759000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/74\/10\/1352\/8520882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":81,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,3,13]]},"published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajrcmb\/aanag042","relation":{},"ISSN":["1535-4989"],"issn-type":[{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,3,13]]}}}